NextFin News - The Trump administration has proposed a new 12.5% tariff on Swiss imports, a move that threatens to disrupt ongoing trade negotiations between Washington and Bern. U.S. Trade Representative Jamieson Greer announced the proposal on Wednesday, citing a Section 301 investigation into the alleged failure of major trading partners to prevent the importation of goods made with forced labor. Switzerland is among 60 economies targeted in this latest trade enforcement action, which also includes the European Union, the United Kingdom, Canada, and Mexico.
The timing of the announcement is particularly sensitive for Swiss officials, who have been engaged in high-stakes discussions to secure a "Fair, Balanced, and Reciprocal Trade" agreement with the United States. According to the Swiss State Secretariat for Economic Affairs (SECO), the new levies under Section 122 of the US Trade Act are intended to replace existing country-specific tariffs for a 150-day period, rather than being levied cumulatively. However, the introduction of a fresh 12.5% barrier complicates a relationship that had seen a brief moment of de-escalation in late 2025, when the U.S. agreed to reduce certain tariffs to 15% from a peak of 32%.
The U.S. Trade Representative’s office framed the move as a necessary step to protect American commerce from the "unacceptable" failure of partners to address forced labor in their supply chains. For Switzerland, the stakes are disproportionately high. The U.S. is Switzerland's second-largest trading partner, and Swiss non-agricultural exporters already face significant customs hurdles. Historical data suggests that Swiss firms pay hundreds of millions of francs in duties annually to access the U.S. market, a burden that would grow substantially under the proposed 12.5% across-the-board hike.
While the Trump administration maintains that these measures are essential for fair trade, some trade analysts suggest the forced labor probe may be serving as a broader lever for the President’s "America First" agenda. The inclusion of traditional allies like Switzerland and the UK in a probe typically associated with high-risk manufacturing hubs indicates a shift toward more aggressive, universal enforcement. This strategy appears designed to force concessions in bilateral talks, though it risks alienating partners who are already navigating a complex global regulatory environment.
The Swiss government has signaled its intent to continue negotiations despite the new pressure. SECO has clarified that while pharmaceutical products will face additional tariffs under Section 232 starting July 31, 2026, the broader 12.5% proposal remains subject to the ongoing diplomatic dialogue. The outcome of these talks will likely determine whether Switzerland can secure an exemption or if its high-value exports—ranging from precision machinery to luxury watches—will face a permanent increase in the cost of doing business in America.
Explore more exclusive insights at nextfin.ai.
